Furthermore, a potential proangiogenic effect related to the vascular endothelial growth factor (VEGF) and VEGF receptors, the possibility of development of pulmonary hypertension, and the potential progression of kidney disease related to HIF activation over long periods, are three interesting questions [37,73]. This evidence concerns the gene VEGFA and pulmonary arterial hypertension.